Emily L. Rickert, Ph.D. - Related publications

2008 Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Pharmacology, Pharmaceutical Chemistry, Biochemistry
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
15 most relevant papers in past 60 days:
Year Citation  Score
2021 Ge J, Chen Y, Yang H, Zhao J, Ren D, Wu X. Expression and significance of estrogen receptor and progesterone receptor in endometrial tissue of patients with intrauterine adhesions. Gland Surgery. 10: 1478-1486. PMID 33968699 DOI: 10.21037/gs-21-232   
2021 Sellami A, Montes M, Lagarde N. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods. International Journal of Molecular Sciences. 22. PMID 33799614 DOI: 10.3390/ijms22062846   
2021 Tan J, Song C, Wang D, Hu Y, Liu D, Ma D, Gao Q. Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer. Bioscience Reports. PMID 33891016 DOI: 10.1042/BSR20210478   
2021 He S, Li X, Ma JZ, Yang Y, Luo S, Xie XD, Yan BH, Yang J, Luo L, Cao LY. The potential endocrine disruption mechanism of anthelmintic drug niclosamide by activating estrogen receptors and estrogen-related receptors. Toxicology. 152805. PMID 33961950 DOI: 10.1016/j.tox.2021.152805   
2021 Glushkov A, Polenok E, Gordeeva L, Mun S, Kostyanko M, Antonov A, Verzhbitskaya N, Vafin I. Immuno-hormonal network in postmenopausal women: disturbance in breast cancer patients. Central-European Journal of Immunology. 46: 68-75. PMID 33897286 DOI: 10.5114/ceji.2021.104462   
2021 Sixto-López Y, Marhuenda E, García-Vazquez JB, Fragoso-Vazquez MJ, Rosales-Hernández MC, Zacarías-Lara O, Méndez-Luna D, Gómez-Vidal JA, Cornu D, Norbert B, Correa-Basurto J. Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells. Cellular and Molecular Neurobiology. PMID 33740172 DOI: 10.1007/s10571-021-01072-9   
2021 Houck KA, Patlewicz G, Richard A, Williams AJ, Shobair MA, Smeltz M, Clifton MS, Wetmore B, Medvedev A, Makarov S. Bioactivity Profiling of Per- and Polyfluoroalkyl Substances (PFAS) Identifies Potential Toxicity Pathways Related to Molecular Structure. Toxicology. 152789. PMID 33887376 DOI: 10.1016/j.tox.2021.152789   
2021 Lüftner D, Tesch H, Schmidt M, Hartkopf AD, Streicher S, Resch A, Genovese L, Rosé C, Valenti R, Harbeck N. Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET study. European Journal of Cancer (Oxford, England : 1990). 150: 268-277. PMID 33971386 DOI: 10.1016/j.ejca.2021.03.045   
2021 Mottamal M, Kang B, Peng X, Wang G. From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target. Acs Omega. 6: 9334-9343. PMID 33869913 DOI: 10.1021/acsomega.0c06362   
2021 Al Abri S, Al Rawahi A, Rao L. Elastosis in Breast Cancer as a Surrogate Marker for Estrogen Receptor Positivity. Oman Medical Journal. 36: e247. PMID 33898059 DOI: 10.5001/omj.2021.60   
2021 Liu Y, Wang C, Li J, Zhu J, Zhao C, Xu H. Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer. Frontiers in Pharmacology. 12: 633453. PMID 33981224 DOI: 10.3389/fphar.2021.633453   
2021 Barroso A, Mahler JV, Fonseca-Castro PH, Quintana FJ. The aryl hydrocarbon receptor and the gut-brain axis. Cellular & Molecular Immunology. 18: 259-268. PMID 33408340 DOI: 10.1038/s41423-020-00585-5   
2021 Sabouni R, Archer DF, Jacot T. Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells. Reproductive Sciences (Thousand Oaks, Calif.). PMID 33559058 DOI: 10.1007/s43032-020-00433-x   
2021 Wang D, Wang M, Sun P, Gao Q. Eplerenone inhibits oxidized low-density lipoprotein-induced proliferation and migration of vascular smooth muscle cells by downregulating GPER expression. Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University. PMID 33915037 DOI: 10.17219/acem/133484   
2021 Johnson A, Zhang H, Gonzalez SR, Lee M, Wei T, Richter G. Presence of estrogen and progesterone receptors in proliferating and involuting infantile hemangiomas. Journal of Plastic, Reconstructive & Aesthetic Surgery : Jpras. PMID 34011473 DOI: 10.1016/j.bjps.2021.03.100